Actively Recruiting

Phase Not Applicable
Age: 30Years - 80Years
All Genders
ID06874803

Effect of "Qi-Tonifying, Yang-Warming, and Water-Resolving" Acupuncture and Moxibustion for Motor Symptom Improvement in Early Parkinson's Disease (WARMED): A Randomized Controlled Trial

Led by Jiani Wu · Updated on 2025-07-20

60

Participants Needed

1

Research Sites

52 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the clinical effects and safety of acupuncture combined with moxibustion in improving motor symptoms for patients with early-stage Parkinson's Disease (PD). This study aims to assess changes in UPDRS scores to understand how these therapies may affect PD symptoms. Additionally, the study explores objective factors influencing acupuncture's effectiveness and investigates brain activity changes using functional MRI. Participants are randomly assigned to one of two groups. One group receives acupuncture and moxibustion therapy at specific points three times a week for eight weeks, alongside their regular PD medication which remains unchanged. The other group undergoes sham acupuncture and sham moxibustion treatments at non-acupuncture points on the same schedule, also continuing their usual PD medications. Throughout the study, participants will be evaluated at baseline, after the 8-week treatment, and at 8 weeks post-treatment (week 16). Assessments include motor symptom scores (MDS-UPDRS part III and II), rigidity and bradykinesia ratings (VAS scores), overall PD symptom scales, quality of life questionnaires (PDQ-39), sleep and mood scales (PDSS, SDS, SAS), and functional MRI scans. Researchers will monitor changes and subgroup factors like age, gender, and disease severity to understand treatment impact and safety over the study period.

CONDITIONS

Brief Title

Acupuncture and Moxibustion for Motor Symptoms in Early Parkinson's Disease

Who Can Participate

Age: 30Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed with Parkinson's Disease according to the 2016 Chinese Diagnostic Criteria
  • Hoehn-Yahr stage less than 3 (mild to moderate PD)
  • Between 30 and 80 years of age inclusive
  • Signed informed consent indicating voluntary participation
Not Eligible

You will not qualify if you...

  • Diagnosed with Parkinson-plus syndromes or other secondary parkinsonism
  • Prior history of deep brain stimulation surgery
  • Severe cerebrovascular disease, brain trauma, or history of craniotomy
  • Severe dementia or psychiatric disorders preventing cooperation
  • Severe coagulation disorders
  • Severe systemic organ dysfunction (cardiac, pulmonary, hepatic, renal, endocrine, or metabolic)
  • Pregnant or breastfeeding women
  • History of allergic reaction to acupuncture or moxibustion
  • Received acupuncture or moxibustion within the past three months
  • Participation in another clinical trial within the past three months

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 8 weeks

Participants receive acupuncture and moxibustion therapy or sham procedures alongside their standard Parkinson's disease medication.

3 visits per week for 8 weeks (24 total sessions)

Follow-up

Duration - 8 weeks

Participants are monitored for changes in motor symptoms and other measures after completing the treatment phase.

Visits at week 16 for follow-up assessments

Trial Site Locations

Total: 1 location

1

Guang'anmen Hospita, China Academy of Chinese Medical Sciences

Beijing, Beijing Municipality, China, 100000

Actively Recruiting

Loading map...

Research Team

Y

Yu Liu, MD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

Phase 1 Study to Evaluate [18F]ACI-15916 as a Potential PET ...

Parkinson's Disease (PD)

Actively Recruiting

1 location

A Phase 2 Randomized, Double-blind, Placebo-Controlled Study...

Parkinson's Disease (PD)

Actively Recruiting

1 location

A Multi-part, Adaptive Phase 1 Study to Assess Safety, Toler...

Parkinson's Disease (PD)

Actively Recruiting

5 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here